D
DNLI
Denali Therapeut
19.91
-0.09-0.45%After Hours: 19.91 0.00 0.00%19:30 10/05 EDT
OPEN/PREV CLOSE20.09/20.00
TODAY RANGE19.54-20.09
VOL1.72M
MARKET CAP3.18B
52 WEEK RANGE13.75-27.30
AVG VOL (3M)1.57M
% TURNOVER0.74%
TURNOVER--
P/E (TTM)-7.0162
% RANGE2.78%
EPS(TTM)-2.8377
P/E(FORWARD)-8.6095
P/B3.808
BVPS5.23
DIVIDEND--
P/S7.15
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.01B
SHARES OUTSTANDING159.85M
NEXT EARNINGS11/04-11/09
FREE FLOAT151.09M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·09/16 15:23
Denali Therapeutics (DNLI) Pulls Back As Pipeline Promise Keeps Fair Value In Focus
Simply Wall St·09/12 10:18
Denali Therapeutics (DNLI) Stock Looks Stretched On Fair Value Yet Reasonable On Book Value
TipRanks·09/10 02:05
Top Executive Makes Eye-Catching Move at Denali Therapeutics
Simply Wall St·09/08 21:32
Is Denali Therapeutics (DNLI) Still Undervalued On Its Mixed Valuation Signals?
Simply Wall St·08/26 17:33
Denali Therapeutics (DNLI) Stock Looks Rich On Book Value While Returns Stay Strong
Dow Jones·08/25 17:57
Denali Therapeutics Is Maintained at Buy by B. Riley Securities
Simply Wall St·08/25 01:26
Denali Therapeutics (DNLI) Stock Dropped, So Why Is It Drawing Fresh Attention?
Seeking Alpha·08/19 12:01
Denali Therapeutics: Bullish On Avlayah And Their Prospects
Seeking Alpha·08/18 15:45
Monopar: Licensing Agreement And Rolling NDA Submission Serve As Catalysts For 'Strong Buy'
Simply Wall St·08/17 16:27
Denali Therapeutics (DNLI) Could Be 42% Undervalued Following Its Earnings Report
Simply Wall St·08/15 03:43
Will AVLAYAH’s Launch And Cash Windfall Reshape Denali Therapeutics' (DNLI) Investment Narrative
TipRanks·08/14 02:07
Top Denali Therapeutics Executive Makes Notable Move With Insider Stock Sale
Same Industry
Name/Symbol
Change%
Price